4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-033737
Options or other derivatives
- Chief Innovation/Tech Officer acquired 356,741 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schobel Alexander Mark · Chief Innovation/Tech Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-07-24 | Grant or award : show line 1 in the form Stock Option (Right to Purchase) | +240,165 | 240,165 | D |
| 2018-07-24 | Grant or award : show line 2 in the form Restricted Stock Unit | +116,576 | 116,576 | D |
Loading xslF345X03/form4.xml…